27
Feb
Medications
Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents
Paragraph IV patent challenges let generic drug makers legally fight brand patents to bring cheaper medicines to market faster. Under the Hatch-Waxman Act, this system has saved U.S. consumers over $1.2 trillion since 1990.